Sandoz Makes Major Moves To Bolster Biosimilars Ahead Of Spinoff

Announces Development Partnership With Evotec And Investment In Holzkirchen Site

 
• By David Wallace
  
Generate a summary of this article
Listen to this article
Beta

Sandoz has made further preparations to bolster its biosimilars business ahead of its spinoff from parent company Novartis, announcing a development and manufacturing deal with Evotec at the same time as unveiling a further investment in its Holzkirchen site to transform it into a biotech development hub.

Sandoz logo on building
Sandoz is building up its biosimilars business before spinning off from Novartis • Source: Shutterstock

Major moves to bolster Sandoz’s biosimilars business ahead of its imminent spinoff from parent company Novartis have been revealed by the firm, in the form of a wide-ranging development and manufacturing partnership with Evotec that is potentially worth hundreds of millions of dollars, as well as a further €25m ($27m) investment in Sandoz’s German Holzkirchen site to transform it into a “state-of-the-art biotech lab” by the end of this year.

Announcing the “multi-year” deal with Seattle-based Evotec subsidiary Just-Evotec Biologics – which has also previously partnered with Biocon (Also see...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.